In one paragraphSynthesis in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 5 institutions in 4 countries.
Giovanna MezaDepartamento de Biología Experimental, Unidad de Inmunogenetica, Universidad de Jaén, Jaén, Spain.ORCID 0000-0002-6604-6699 Fátima GaliánDepartamento de Biología Experimental, Unidad de Inmunogenetica, Universidad de Jaén, Jaén, Spain.
Claudia Jaimes-BernalDepartamento de Biología Experimental, Unidad de Inmunogenetica, Universidad de Jaén, Jaén, Spain.ORCID 0000-0002-8034-190X Francisco J MárquezDepartamento de Biología Experimental, Unidad de Inmunogenetica, Universidad de Jaén, Jaén, Spain.ORCID 0000-0002-1450-6235 Faruk SinangilGlobal Solutions for Infectious Diseases, Lafayette, CA, USA.
Carolina ScagnolariDepartment of Molecular Medicine, Laboratory of Virology, Institut Pasteur Italia, SApienza University of Rome, Rome, Italy.ORCID 0000-0003-1044-1478 Luis Miguel Realde Enfermedades Infecciosas y Microbiología Clínica, Hospital Universitario de Valme, Sevilla, Spain.ORCID 0000-0003-4932-7429 Donald ForthalDivision of Infectious Diseases, Department of Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.ORCID 0000-0001-6687-6775 Antonio CaruzDepartamento de Biología Experimental, Unidad de Inmunogenetica, Universidad de Jaén, Jaén, Spain.ORCID 0000-0002-5788-7840 Universidad de Jaén · ESGlobal Solutions for Infectious Diseases · USHospital Universitario de Valme · ESIstituto Pasteur · ITUniversity of California, Irvine · US
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Individuals lacking interferon lambda 4 (IFNL4) protein due to a common null mutation (rs368234815) in the
Indexed as
HIV-1HIV InfectionsSexual and Gender MinoritiesGenotypeHomosexuality, MaleHumansInterferon LambdaInterferonsInterleukinsMaleSeroconversionIFNL4 protein, humanInterferon LambdaInterferonsInterleukinsHESNHIV-1HIV exposed seronegativeIFNL4IL28B
Identifiers
PMID35481423
PMCPMC9067526
OpenAlexW4225091082
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390